Therapeutic vignette: old and new drugs in mixed connective tissue disease.
Rozenbaum
Michael
M
Department of Rheumatology, Bnai Zion Medical Center, Haifa, Israel.
Slobodin
Gleb
G
Boulman
Nina
N
Feld
Joy
J
Avshovich
Nina
N
Ben-Arieh
Yehudit
Y
Rosner
Itzhak
I
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D015897:Comorbidity; D018450:Disease Progression; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D000069285:Infliximab; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced / Q000453:epidemiology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D008947:Mixed Connective Tissue Disease / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D011193:Potassium Iodide / Q000008:administration & dosage / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage; D012883:Skin Ulcer / Q000188:drug therapy / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors; D014657:Vasculitis / Q000209:etiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D011193:Potassium Iodide; D000069285:Infliximab; D011241:Prednisone; D008727:Methotrexate